{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:58:26Z","timestamp":1760821106384,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T00:00:00Z","timestamp":1571616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Pneumothorax may recur during pulmonary Langerhans cell histiocytosis (PLCH) patients\u2019 follow-up and its management is not standardised. The factors associated with pneumothorax recurrence are unknown.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this retrospective study, PLCH patients who experienced a pneumothorax and were followed for at least 6\u2009months after the first episode were eligible. The objectives were to describe the treatment of the initial episode and pneumothorax recurrences during follow-up. We also searched for factors associated with pneumothorax recurrence and evaluated the effect on lung function outcome. Time to recurrence was estimated by the Kaplan Meier method and the cumulative hazard of recurrence handling all recurrent events was estimated. Univariate Cox models and Andersen-Gill counting process were used for statistical analyses.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Fourty-three patients (median age 26.5\u2009years [interquartile range (IQR), 22.9\u201335.4]; 26 men, 39 current smokers) were included and followed for median time of 49\u2009months. Chest tube drainage was the main management of the initial pneumothorax, which resolved in 70% of cases. Pneumothorax recurred in 23 (53%) patients, and overall 96 pneumothoraces were observed during the study period. In the subgroup of patients who experienced pneumothorax recurrence, the median number of episodes per patient was 3 [IQR, 2\u20134]. All but one recurrence occurred within 2\u2009years after the first episode. Thoracic surgery neither delayed the time of occurrence of the first ipsilateral recurrence nor reduced the overall number of recurrences during the study period, although the rate of recurrence was lower after thoracotomy than following video-assisted thoracic surgery (<jats:italic>p<\/jats:italic>\u2009=\u20090.03). At the time of the first pneumothorax, the presence of air trapping on lung function testing was associated with increased risk of recurrence (hazard ratio\u2009=\u20095.08; 95% confidence interval [1.18, 21.8]; p\u2009=\u20090.03). Pneumothorax recurrence did not predict subsequent lung function decline (<jats:italic>p<\/jats:italic>\u2009=\u20090.058).<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our results show that pneumothorax recurrences occur during an \u201cactive\u201d phase of PLCH. In this observational study, the time of occurrence of the first ipsilateral recurrence and the overall number of pneumothorax recurrences were similar after conservative and thoracic surgical treatments. Further studies are needed to determine the best management to reduce the risk of pneumothorax recurrence in PLCH patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-019-1203-5","type":"journal-article","created":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T16:20:27Z","timestamp":1571674827000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management and outcomes of pneumothorax in adult patients with Langerhans cell Histiocytosis"],"prefix":"10.1186","volume":"14","author":[{"given":"Pierre","family":"Le Guen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Chevret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Bugnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constance","family":"de Margerie-Mellon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwena\u00ebl","family":"Lorillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathe","family":"Seguin-Givelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan\u00e9lie","family":"Jouenne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominique","family":"Gossot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Vassallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0788-7444","authenticated-orcid":false,"given":"Abdellatif","family":"Tazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,21]]},"reference":[{"issue":"10","key":"1203_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1136\/thoraxjnl-2017-210125","volume":"72","author":"R Vassallo","year":"2017","unstructured":"Vassallo R, Harari S, Tazi A. Current understanding and management of pulmonary Langerhans cell histiocytosis. Thorax. 2017;72(10):937\u201345.","journal-title":"Thorax"},{"issue":"6","key":"1203_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00408-018-0155-1","volume":"196","author":"E Radzikowska","year":"2018","unstructured":"Radzikowska E, Blasinska-Przerwa K, Wiatr E, Bestry I, Langfort R, Roszkowski-Sliz K. Pneumothorax in patients with pulmonary Langerhans cell Histiocytosis. Lung. 2018;196(6):715\u201320.","journal-title":"Lung"},{"issue":"3","key":"1203_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1378\/chest.125.3.1028","volume":"125","author":"JL Mendez","year":"2004","unstructured":"Mendez JL, Nadrous HF, Vassallo R, Decker PA, Ryu JH. Pneumothorax in pulmonary Langerhans cell histiocytosis. Chest. 2004;125(3):1028\u201332.","journal-title":"Chest"},{"issue":"Suppl 2","key":"1203_CR4","doi-asserted-by":"publisher","first-page":"ii18","DOI":"10.1136\/thx.2010.136986","volume":"65","author":"A MacDuff","year":"2010","unstructured":"MacDuff A, Arnold A, Harvey J. Management of spontaneous pneumothorax: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii18\u201331.","journal-title":"Thorax"},{"key":"1203_CR5","doi-asserted-by":"publisher","first-page":"g2928","DOI":"10.1136\/bmj.g2928","volume":"348","author":"O Bintcliffe","year":"2014","unstructured":"Bintcliffe O, Maskell N. Spontaneous pneumothorax. BMJ. 2014;348:g2928.","journal-title":"BMJ"},{"issue":"2","key":"1203_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1183\/09031936.00219214","volume":"46","author":"JM Tschopp","year":"2015","unstructured":"Tschopp JM, Bintcliffe O, Astoul P, Canalis E, Driesen P, Janssen J, et al. ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax. Eur Respir J. 2015;46(2):321\u201335.","journal-title":"Eur Respir J"},{"issue":"145","key":"1203_CR7","doi-asserted-by":"publisher","first-page":"170070","DOI":"10.1183\/16000617.0070-2017","volume":"26","author":"Gwena\u00ebl Lorillon","year":"2017","unstructured":"Lorillon G, Tazi A. How I manage pulmonary Langerhans cell histiocytosis. Eur Respir Rev. 2017:26(145).","journal-title":"European Respiratory Review"},{"issue":"5","key":"1203_CR8","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1378\/chest.129.5.1274","volume":"129","author":"KF Almoosa","year":"2006","unstructured":"Almoosa KF, Ryu JH, Mendez J, Huggins JT, Young LR, Sullivan EJ, et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest. 2006;129(5):1274\u201381.","journal-title":"Chest"},{"issue":"4","key":"1203_CR9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/MCP.0000000000000391","volume":"23","author":"J Cooley","year":"2017","unstructured":"Cooley J, Lee YCG, Gupta N. Spontaneous pneumothorax in diffuse cystic lung diseases. Curr Opin Pulm Med. 2017;23(4):323\u201333.","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"1203_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1513\/AnnalsATS.201611-886OC","volume":"14","author":"N Gupta","year":"2017","unstructured":"Gupta N, Kopras EJ, Henske EP, James LE, El-Chemaly S, Veeraraghavan S, et al. Spontaneous Pneumothoraces in patients with Birt-Hogg-Dube syndrome. Ann Am Thorac Soc. 2017;14(5):706\u201313.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"1203_CR11","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13023-017-0651-z","volume":"12","author":"A Tazi","year":"2017","unstructured":"Tazi A, Lorillon G, Haroche J, Neel A, Dominique S, Aouba A, et al. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study. Orphanet J Rare Dis. 2017;12(1):95.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"1203_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1183\/09031936.00210711","volume":"40","author":"A Tazi","year":"2012","unstructured":"Tazi A, Marc K, Dominique S, de Bazelaire C, Crestani B, Chinet T, et al. Serial computed tomography and lung function testing in pulmonary Langerhans' cell histiocytosis. Eur Respir J. 2012;40(4):905\u201312.","journal-title":"Eur Respir J"},{"issue":"1","key":"1203_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13023-015-0249-2","volume":"10","author":"A Tazi","year":"2015","unstructured":"Tazi A, de Margerie C, Naccache JM, Fry S, Dominique S, Jouneau S, et al. The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study. Orphanet J Rare Dis. 2015;10(1):30.","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"1203_CR14","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1183\/13993003.01677-2015","volume":"47","author":"S Mourah","year":"2016","unstructured":"Mourah S, How-Kit A, Meignin V, Gossot D, Lorillon G, Bugnet E, et al. Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis. Eur Respir J. 2016;47(6):1785\u201396.","journal-title":"Eur Respir J"},{"issue":"4","key":"1203_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1214\/aos\/1176345976","volume":"10","author":"PK Andersen","year":"1982","unstructured":"Andersen PK, Gill RD. Cox's regression model for counting processes: a large sample study. Ann Stat. 1982;10(4):1100\u201320.","journal-title":"Ann Stat"},{"issue":"1","key":"1203_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1513\/AnnalsATS.201606-459OC","volume":"14","author":"N Gupta","year":"2017","unstructured":"Gupta N, Langenderfer D, McCormack FX, Schauer DP, Eckman MH. Chest computed tomographic image screening for cystic lung diseases in patients with spontaneous pneumothorax is cost effective. Ann Am Thorac Soc. 2017;14(1):17\u201325.","journal-title":"Ann Am Thorac Soc"},{"issue":"9584","key":"1203_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0140-6736(07)61163-5","volume":"370","author":"A Barker","year":"2007","unstructured":"Barker A, Maratos EC, Edmonds L, Lim E. Recurrence rates of video-assisted thoracoscopic versus open surgery in the prevention of recurrent pneumothoraces: a systematic review of randomised and non-randomised trials. Lancet. 2007;370(9584):329\u201335.","journal-title":"Lancet"},{"issue":"6","key":"1203_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11748-012-0080-9","volume":"60","author":"A Bille","year":"2012","unstructured":"Bille A, Barker A, Maratos EC, Edmonds L, Lim E. Surgical access rather than method of pleurodesis (pleurectomy or pleural abrasion) influences recurrence rates for pneumothorax surgery: systematic review and meta-analysis. Gen Thorac Cardiovasc Surg. 2012;60(6):321\u20135.","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"5","key":"1203_CR19","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1097\/01.tp.0000200304.64613.af","volume":"81","author":"G Dauriat","year":"2006","unstructured":"Dauriat G, Mal H, Thabut G, Mornex JF, Bertocchi M, Tronc F, et al. Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis. Transplantation. 2006;81(5):746\u201350.","journal-title":"Transplantation"},{"issue":"1","key":"1203_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1183\/09031936.00076209","volume":"35","author":"SR Johnson","year":"2010","unstructured":"Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010;35(1):14\u201326.","journal-title":"Eur Respir J"},{"issue":"5","key":"1203_CR21","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/j.1600-6143.2011.03946.x","volume":"12","author":"N Shigemura","year":"2012","unstructured":"Shigemura N, Bhama J, Gries CJ, Kawamura T, Crespo M, Johnson B, et al. Lung transplantation in patients with prior cardiothoracic surgical procedures. Am J Transplant. 2012;12(5):1249\u201355.","journal-title":"Am J Transplant"},{"issue":"4","key":"1203_CR22","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/PAS.0000000000000129","volume":"38","author":"AC Roden","year":"2014","unstructured":"Roden AC, Hu X, Kip S, Parrilla Castellar ER, Rumilla KM, Vrana JA, et al. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol. 2014;38(4):548\u201351.","journal-title":"Am J Surg Pathol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1203-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1203-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1203-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T23:06:20Z","timestamp":1603148780000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1203-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,21]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1203"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1203-5","relation":{},"ISSN":["1750-1172"],"issn-type":[{"type":"electronic","value":"1750-1172"}],"subject":[],"published":{"date-parts":[[2019,10,21]]},"assertion":[{"value":"1 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was performed in accordance with the Helsinki Declaration and approved by the Institutional Review Board of the French Institute of Medical Research and Health (IRB number17\u2013395). All patients provided written informed consent for the use of their medical reports for research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Le Guen declares travel accommodations from LVL Medical and Novartis.Dr. Chevret has no conflicts of interest to declare.Dr. Bugnet has no conflicts of interest to declare.Dr. de Margerie-Mellon has received grants from Institut Servier and Olea Medical.Dr. Lorillon declares travel accommodations from Vitalaire and Chiesi.Dr. Seguin-Givelet has no conflicts of interest to declare.Dr. Jouenne has no conflicts of interest to declare.Dr. Gossot has no conflicts of interest to declare.Dr. Vassallo has received research funding from Pfizer, Bristol Myers Squibb, and Sun Pharma.Dr. Tazi declares speaker fees from BMS and travel accommodations from Boehringer Ingelheim, Astrazeneca, Vitalaire and Teva.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}